DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

Why did Jeep recall 375,000 SUVs? How did Zohran Mamdani win NYC mayoral race? What caused Bitcoin to drop below $100K again? Why is Amazon suing AI startup Perplexity? How will EU climate deal impact emissions by 2040? What triggered IBM’s latest wave of layoffs? Why did Toyota lower profit forecasts amid tariffs?

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

benzinga.com/markets/earnings/25/10/48565485/dna-sequencing-firm-illumina-sees-strong-clinical-market-momentum-stock-soars

Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings.
ILMN shares are climbing with conviction. Watch the momentum here
The DNA sequencing company reported adjusted earnings of $1.34 per share, beating the consensus of…

This story appeared on benzinga.com, 2025-10-31 16:01:40.